Board Change • May 01
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Eddy Cheng was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공지 • Feb 27
Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million. Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,171,445,635
Price\Range: AUD 0.0075 공지 • Oct 24
Avenira Limited, Annual General Meeting, Nov 25, 2025 Avenira Limited, Annual General Meeting, Nov 25, 2025. Location: at level 1, suite 9, 110 hay st, subiaco, wa 6008 Australia Board Change • Aug 18
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Eddy Cheng was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공지 • Mar 10
Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million. Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,081,000,000
Price\Range: AUD 0.007
Transaction Features: Subsequent Direct Listing Board Change • Dec 31
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. CEO & Chairman Stephanie Yuan was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 공지 • Dec 03
Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million. Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 285,000,000
Price\Range: AUD 0.006
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 465,000,000
Price\Range: AUD 0.006
Transaction Features: Subsequent Direct Listing 공지 • Oct 30
Avenira Limited, Annual General Meeting, Nov 29, 2024 Avenira Limited, Annual General Meeting, Nov 29, 2024. Location: physical meeting at: unit 12 / 217 hay st, subiaco, wa 6008 Australia 공지 • Sep 10
Avenira Limited Announces Board Changes Avenira Limited advised that following an internal transfer/promotion by major shareholder Hebang Biotechnology, Mr. Mo Yang has resigned as a director of Avenira and has been replaced by Ms Yuan (Stephanie) Yuan. Ms Yuan has been a Board Secretary and Board member of various Hebang companies over the past 10 years. Ms Yuan has a Master of Management Accounting and a Master Of Philosophy from Melbourne University, and a Bachelor of Medicine from Tongji University in China. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board. New Risk • Aug 04
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 56% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (30% average weekly change). Earnings have declined by 38% per year over the past 5 years. Shareholders have been substantially diluted in the past year (56% increase in shares outstanding). Revenue is less than US$1m (AU$1.0k revenue, or US$684). Minor Risk Market cap is less than US$100m (AU$27.0m market cap, or US$17.6m). 공지 • Jul 03
Avenira Limited Announces Board Resignations Avenira Limited announced that Directors Mr. Kevin Dundo and Ms. Winnie Lai Hadad have resigned from the Board of Directors effective July 2, 2024. New Risk • Apr 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.73m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 38% per year over the past 5 years. Shareholders have been substantially diluted in the past year (100% increase in shares outstanding). Revenue is less than US$1m (AU$1.0k revenue, or US$684). Market cap is less than US$10m (AU$14.9m market cap, or US$9.73m). 공지 • Apr 05
Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 156,462,500
Price\Range: AUD 0.008
Discount Per Security: AUD 0.00048
Transaction Features: Subsequent Direct Listing New Risk • Apr 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 38% per year over the past 5 years. Shareholders have been substantially diluted in the past year (87% increase in shares outstanding). Revenue is less than US$1m (AU$1.0k revenue, or US$691). Minor Risk Market cap is less than US$100m (AU$16.3m market cap, or US$10.7m). Board Change • Apr 05
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Eddy Cheng was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 공지 • Apr 04
Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 156,462,500
Price\Range: AUD 0.008
Discount Per Security: AUD 0.00048
Transaction Features: Subsequent Direct Listing 공지 • Mar 18
Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million. Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 137,125,000
Price\Range: AUD 0.08
Discount Per Security: AUD 0.0048
Transaction Features: Subsequent Direct Listing New Risk • Dec 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 74% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 28% per year over the past 5 years. Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m (AU$5.8k revenue, or US$3.9k). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (AU$28.2m market cap, or US$18.9m). 공지 • Dec 13
Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited On December 11, 2023, Avenira Limited closed the transaction. 공지 • Dec 07
Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million. Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 181,818,182
Price\Range: AUD 0.011
Discount Per Security: AUD 0.00066
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 252,496,129
Price\Range: AUD 0.011
Discount Per Security: AUD 0.00066
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 21,000,000
Price\Range: AUD 0.011
Discount Per Security: AUD 0.00066
Transaction Features: Subsequent Direct Listing 공지 • Dec 06
Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 181,818,182
Price\Range: AUD 0.011
Transaction Features: Subsequent Direct Listing 공지 • Dec 05
Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited Avenira Limited announced that it has entered into a share purchase agreement to issue 181,818,182 common shares at a price of AUD 0.011 per share for the gross proceeds of AUD 2,000,000 on December 4, 2023. The transaction will include participation from new investor, Sichuan Hebang Biotechnology Corporation Limited. Post the completion of the transaction, the investor, will become a substantial shareholder in the issued capital of the company. The placement will be completed in one tranche. 공지 • Oct 31
Avenira Limited, Annual General Meeting, Nov 29, 2023 Avenira Limited, Annual General Meeting, Nov 29, 2023, at 13:30 W. Australia Standard Time. Location: Level 1, Suite 9, 110 Hay Street, Subiaco, WA Subiaco Australia Agenda: To receive and consider the Annual Report of the Company for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report (including the Remuneration Report) and the Auditor's Report; to consider Adoption of Remuneration Report; to consider Re-election of Mr Brett Clark as a Director; to consider Re-election of Mr Roger Harris as a Director; to consider Election of Mr Nam (Eddy) Cheng as a Director; to consider Ratification of Issue of Securities; to consider Approval for the Issue of Lead Manager Options to Petra Capital Pty Ltd; and to consider other business matters. New Risk • Oct 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.7m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 28% per year over the past 5 years. Revenue is less than US$1m (AU$5.8k revenue, or US$3.7k). Minor Risks Shareholders have been diluted in the past year (41% increase in shares outstanding). Market cap is less than US$100m (AU$18.9m market cap, or US$12.0m). New Risk • Sep 29
New major risk - Revenue and earnings growth Earnings have declined by 28% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.7m free cash flow). Earnings have declined by 28% per year over the past 5 years. Revenue is less than US$1m (AU$58k revenue, or US$38k). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (42% increase in shares outstanding). Market cap is less than US$100m (AU$19.0m market cap, or US$12.3m). 공지 • Jun 22
Avenira Limited Announces Board Changes Avenira Limited announces the resignation of Dr Geoffrey Xue as a director of the Company. On 14 June 2021 shareholder approval was obtained in relation to the $3 million Convertible Loan Agreement between the Company and Au Xingao Investment Pty Ltd, as Lender (Au Xingao). The notice of meeting set out that under the Convertible Loan Agreement the Lender could nominate two persons to be directors of the Company. On 9 July 2021 Mr. Roger Harris was appointed as a nominee of the Lender and the second nominee Dr Geoffrey Xue was appointed on 21 July 2021. While the loan remains payable on or before 8 March 2024, the Lender can maintain two nominee directors on the Company's board and if one or both resign the Lender can nominate a replacement. Due to other commitments Dr Geoffrey Xue has tendered his resignation as a director of the Company. The Company wishes to thank Dr Xue for his contribution over the last two years and in particular his expertise in geological and technical fields that has been highly valued by the Board. Au Xingao has nominated Mr. Eddy Cheng as the replacement for Dr Xue. Mr. Cheng's experience has been in business development, strategic planning and market analysis and will add a further skilllset to the Board as it seeks to develop the Wonarah Project. 공지 • May 25
Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million. Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 281,763,677
Price\Range: AUD 0.011
Discount Per Security: AUD 0.00066
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 172,781,778
Price\Range: AUD 0.011
Discount Per Security: AUD 0.00066
Transaction Features: Subsequent Direct Listing Board Change • Nov 18
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non- Executive Director Roger Harris was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 27
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. No independent directors (5 non-independent directors). Executive Chairman & CEO Brett Clark is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. 
